Background People have come to rely on restaurants and takeaway foods, and less on cooking at home. We examined the ...

Postlaminectomy syndrome after posterior lumbar fusion was associated with significantly increased long-term risk for major cardiac events.

Periconceptional exposure to glucagon-like peptide-1 (GLP-1) receptor agonists is associated with increased odds of preterm ...

Early ketamine administration for severe traumatic brain injury is associated with a significantly reduced risk for mortality and brain death.

Recent data suggests people taking GLP-1 drugs may develop colorectal cancer less often than those taking aspirin, a ...

For adults aged 50 years and older with a diagnosis of atherosclerotic cardiovascular disease (ASCVD), herpes zoster (HZ) ...

The use of GLP-1 RAs is associated with a significantly lower risk of legal blindness in patients with type 2 diabetes mellitus.

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

Among patients with cancer, brain metastases, and type 2 diabetes, GLP-1 use is associated with lower all-cause mortality, ...

For patients with obesity and atrial fibrillation (Afib), GLP-1 receptor agonist drugs may be the weight loss approach that ...

Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for risk stratification remain elusive. This study sought to explore the ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.